Zandu Pharma Plans To Merger With Emami

Zandu Pharmaceutical has announced that the company has received approval from the shareholders for merger with Emami and Emami Infrastructure.

Zandu Pharmaceutical had conducted ameeting with the company’s equity shareholders on September 11, where 99.87% of shareholders voted unanimously in favour of the merger.

According to the BSC filing – “A majority of the shareholders of Zandu Pharmaceutical Works, holding more than 75% of the value of shares, present and voting have passed the resolution approving the scheme of arrangement.”

Moreover, the Kolkata-based Emami will be segregating markets for products of Emami and Zandu, as brands overlap in some categories.